Delta-Fly Pharma, Inc.'s total assets for Q1 2026 were ¥790.57M, an increase of 82.02% from the previous quarter. JP:4598 total liabilities were ¥137.03M for the fiscal quarter, a -12.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.